Algert Global’s BioTelemetry, Inc. BEAT Stock Holding History

Algert Global’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-11,640	Closed	-$531K	–	544
2020 Q3	$531K	Sell	11,640 -534	-4%	-$22.3K	0.17%	183
2020 Q2	$550K	Buy	12,174 +1,057	+10%	+$47.4K	0.19%	170
2020 Q1	$428K	Buy	+11,117	New	+$512K	0.18%	187
2017 Q1	–	Sell	-22,974	Closed	-$513K	–	411
2016 Q4	$513K	Buy	22,974 +4,353	+23%	+$85.1K	0.15%	228
2016 Q3	$346K	Buy	+18,621	New	+$351K	0.1%	283
2015 Q3	–	Sell	-47,599	Closed	-$449K	–	387
2015 Q2	$449K	Hold	47,599	–	–	0.25%	156
2015 Q1	$421K	Sell	47,599 -14,367	-23%	-$145K	0.23%	169
2014 Q4	$622K	Hold	61,966	–	–	0.37%	109
2014 Q3	$416K	Hold	61,966	–	–	0.31%	131
2014 Q2	$444K	Sell	61,966 -6,718	-10%	-$53.5K	0.29%	142
2014 Q1	$693K	Buy	68,684 +4,357	+7%	+$40.1K	0.27%	135
2013 Q4	$511K	Buy	64,327 +13,610	+27%	+$127K	0.14%	215
2013 Q3	$503K	Hold	50,717	–	–	0.14%	205
2013 Q2	$299K	Buy	+50,717	New	+$171K	0.09%	227

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return

SGCM

Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Algert Global's BEAT Position: Q4 2020 in Review

Algert Global sold out of BioTelemetry, Inc. (BEAT) in Q4 2020, closing a stake of 11,640 shares — an estimated $531K sold.

Algert Global first reported a position in BEAT in Q2 2013 and held it in 14 quarters. The position peaked at $693K in Q1 2014. 238 funds tracked by Wall St. Rank hold BEAT as of Q4 2020.

Algert Global reported no remaining BioTelemetry, Inc. position as of Q4 2020 after selling out during the quarter.
Algert Global sold 11,640 BioTelemetry, Inc. shares in Q4 2020, an estimated $531K.
Algert Global first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 14 quarters.
Algert Global's BioTelemetry, Inc. position peaked at $693K in Q1 2014.
238 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2020.

Based on Algert Global's 13F filing for Q4 2020, filed 12 Feb 2021.